I am currently a Junior Faculty in the Department of Medicine (Division of Endocrinology, Diabetes & Metabolism) at University of Illinois at Chicago. My main area of interest is in metabolic reprogramming in cancer. The goal of my research is to identify the mechanisms by which novel proteins modify cellular metabolism in order for cells to acquire tumorigenic properties. These studies will provide mechanistic insights into how metabolic reprogramming helps carcinogenesis and may identify new targets for future intervention and novel therapeutic approaches to the current cancer epidemic. My long-term career goal is to establish myself as an independent PI with required expertise so that I can be at the forefront of understanding the molecular pathways mediating cancer. I have been working on an independent project that investigates the mechanistic role of HKDC1 in HCC (hepatocellular carcinoma) growth and proliferation. I have exciting preliminary data that links HKDC1 with two of the most significant liver pathophysiological conditions of our times, NASH and HCC. I have recently been funded by the DOD (Career Development Grant) to complete this research project.